Alkermes
ALKS
#3093
Rank
C$6.73 B
Marketcap
C$40.78
Share price
0.75%
Change (1 day)
-6.75%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.82 Billion

According to Alkermes's latest financial reports the company's total liabilities are C$0.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.84 B-31.55%
2023-12-31C$1.23 B-0.84%
2022-12-31C$1.24 B7.45%
2021-12-31C$1.16 B3.25%
2020-12-31C$1.12 B19.7%
2019-12-31C$0.94 B5.59%
2018-12-31C$0.89 B19.16%
2017-12-31C$0.74 B7.58%
2016-12-31C$0.69 B-7.51%
2015-12-31C$0.75 B23.94%
2014-12-31C$0.60 B
2013-03-31C$0.52 B-9.27%
2012-03-31C$0.58 B890.72%
2011-03-31C$58.59 M-43.57%
2010-03-31C$0.10 B-37.27%
2009-03-31C$0.16 B-53.5%
2008-03-31C$0.35 B-15.77%
2007-03-31C$0.42 B-19.07%
2006-03-31C$0.52 B28.59%
2005-03-31C$0.40 B60.08%
2004-03-31C$0.25 B-33.74%
2003-03-31C$0.38 B-4.24%
2002-03-31C$0.39 B4.34%
2001-03-31C$0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
C$0.36 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.15 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$94.61 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$45.03 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
C$91.21 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
C$86.39 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland